FG020326-loaded nanoparticle with PEG and PDLLA improved pharmacodynamics of reversing multidrug resistance in vitro and in vivo

Acta Pharmacologica Sinica

Volumn 28, Issue 6, 2007, Pages 913-920

  Deng, Wen Jing ^a   Yang, Xiao Qiang ^b   Liang, Yong Ju ^a   Chen, Li Ming ^a   Yan, Yan Yan ^a   Shuai, Xin Tao ^b   Fu, Li Wu ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

FG020326; Micellar nanoparticle; Multidrug resistance; Xenografts

Indexed keywords

COPOLYMER; FG 020326; GLYCOPROTEIN P; IMIDAZOLE DERIVATIVE; MACROGOL BLOCK POLYGLACTIN COPOLYMER; NANOPARTICLE; RHODAMINE 123; TETRAZOLIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACCUMULATION; DRUG ACTIVITY; DRUG DOSAGE FORM COMPARISON; DRUG EFFECT; DRUG SOLUBILITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SPACE; MALE; MOUSE; MULTIDRUG RESISTANCE; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; SPECTROFLUOROMETRY; SQUAMOUS CELL CARCINOMA; TUMOR XENOGRAFT;

ACRYLATES; ANIMALS; CELL LINE; DOXORUBICIN; DRUG CARRIERS; DRUG RESISTANCE, MULTIPLE; HUMANS; IMIDAZOLES; LACTIC ACID; MICE; MICE, NUDE; NANOPARTICLES; POLYETHYLENE GLYCOLS; TRANSPLANTATION, HETEROLOGOUS; VINCRISTINE;

EID: 34249334671     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2007.00565.x     Document Type: Article

References (22)

1. Endicott JA, Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem, 1989 58 : 137 71.
2. Kellen JA. The reversal of multidrug resistance in cancer. Anti-cancer Res, 1993 13 : 959 61.
3. Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev, 2002 54 : 631 51.
4. Barraud L, Merle P, Soma E, Lefrancois L, Guerret S, Chevallier M, et al. Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo. J Hepatol 2005 42 : 736 43.
5. Koziara JM, Whisman TR, Tseng MT, Mumper RJ. In-vivo efficacy of novel paclitaxel nanoparticles in paclitaxel-resistant human colorectal tumors. J Control Release, 2006 112 : 312 9.
6. Kwon GS, Kataoka K. Block copolymer micelles as longcirculating drug vehicles. Adv Drug Deliv, 1995 16 : 295 309.
7. Jones M, Leroux J. Polymeric micelles - a new generation of colloidal drug carriers. Eur J Pharm Biopharm, 1999 48 : 101 11.
8. Maeda H, Fang J, Inutsuka T, Kitamoto Y. Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications. Int Immunopharmacol, 2003 3 : 319 28.
9. Xu P, Van Kirk EA, Li S, Murdoch WJ, Ren J, Hussain MD, et al. Highly stable core-surface-crosslinked nanoparticles as cisplatin carriers for cancer chemotherapy. Colloids Surf B Biointerfaces, 2006 48 : 50 7.
10. Kawano K, Watanabe M, Yamamoto T, Yokoyama M, Opanasopit P, Okano T, et al. Enhanced antitumor effect of camptothecin loaded in long-circulating polymeric micelles. J Control Release, 2006 112 : 329 32.
11. Chen LM, Wu XP, Ruan JW, Liang YJ, Ding Y, Shi Z, et al. Screening novel, potent multidrug-resistant modulators from imidazole derivatives. Oncol Res, 2004 14 : 355 62.
12. Fu LW, He LR, Liang YJ, Chen LM, Xiong HY, Yang XP, et al. Experimental chemotherapy against xenografts derived from multidrug resistant KBv200 cells and parental drug-sensitive KB cells in nude mice by annonaceous acetogenin 89-2. Acta Pharm Sin, 2003 38 : 565 70.
13. Fu LW, Zhang YM, Liang YJ, Yang XP, Pan QC. The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells. Eur J Cancer, 2002 38 : 418 26.
14. Liang YJ, Fu LW, Feng HL, He LR, Feng GK, Yang XP, et al. Establishment of the model of KBv200 nude mice xenograft and studies on its characterization of multidrug resistance. Chin Pharmacol Bull, 2000 16 : 705 9.
15. Yokoyama M, Miyauchi M, Yamada N, Okano T, Sakurai Y, Kataoka K, et al. Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. Cancer Res, 1990 50 : 1693 700.
16. Zhang X, Burt HM, Von Hoff D, Dexter D, Mangold G, Degen D, et al. An investigation of the antitumour activity and biodistribution of polymeric micellar paclitaxel. Cancer Chemother Pharmacol, 1997 40 : 81 6.
17. Zhang X, Burt HM, Mangold G, Dexter D, Von Hoff D, Mayer L, et al. Anti-tumor efficacy and biodistribution of intravenous polymeric micellar paclitaxel. Anticancer Drugs, 1997 8 : 696 701.
18. Yokoyama M, Okano T, Sakurai Y, Ekimoto H, Shibazaki C, Kataoka K. Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res, 1991 51 : 3229 36.
19. Liu Z, Bendayan R, Wu XY. Triton-X-100-modified polymer and microspheres for reversal of multidrug resistance. J Pharm Pharmacol, 2001 53 : 1 12.
20. Li X, Ruan GR, Lu WL, Hong HY, Liang GW, Zhang YT, et al. A novel stealth liposomal topotecan with amlodipine: apoptotic effect is associated with deletion of intracellular Ca2+ by amlodipine thus leading to an enhanced antitumor activity in leukemia. J Control Release, 2006 112 : 186 98.
21. Tsuruo T, Naito M, Tomida A, Fujita N, Mashima T, Sakamoto H, et al. Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal. Cancer Sci, 2003 94 : 15 21.
22. Croce AC, Supino R, Lanza KS, Locatelli D, Baglioni P, Bottiroli G. Photosensitizer accumulation in spontaneous multidrug resistant cells: a comparative study with rhodamine 123, rose bengal acetate and photofrine. Photochem Photobiol Sci, 2002 1 : 71 8.